In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

Firefighters, police officer who responded to 9/11 in World Trade Center do have an increased risk of multiple myeloma. There are some other well-defined occupational exposures. For instance ...

Background: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma liposomes have been linked to MM, ...

The malignant plasma cells replace normal blood cells, which can lead to anaemia, bone marrow failure and renal damage. Over the past two decades the paradigm of multiple myeloma therapy has ...

Jan. 30 (UPI) --Former NBA All-Star and champion Dwyane Wade on Thursday announced he had 40% of his right kidney removed along with a cancerous tumor in December 2023. Wade, 43, announced the ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

Myeloma is considered a devastating disorder of the plasma cells that can result in many complications such as bone fractures, kidney problems, and other blood cell disorders. Although multiple ...

Leg swelling and itching are potential signs of kidney damage caused by multiple myeloma. Your healthcare provider will also probably ask about your medical history. After reviewing your symptoms ...

But after a seemingly random finger fracture, his doctor tested him for elevated protein levels in his blood and told him he had a form of cancer called multiple myeloma. It was sort of an out-of ...

The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refractory multiple myeloma (RRMM) was a critical ...